Presentations

Title File Size Download

VRNA Presentation May 2024

2.0MB

PDF

VRNA Investor Update October 2023

3.99MB

PDF

VRNA ATS 2023 Final

1.61MB

PDF

VRNA ENHANCE 1 Phase 3 top line results

0.90MB

PDF

VRNA ENHANCE 2 Phase 3 top line results Q2

0.95MB

PDF

Developing novel therapeutics for respiratory diseases

Verona Pharma (Nasdaq:VRNA) is focused on delivering our strategy and creating value for shareholders.